NEWS & MEDIA
Exclusive License to Accelerate Development of New Breakthrough Products based on Specific Variants of Human Fibrinogen.
Leiden, The Netherlands, September 24, 2015 – Fibriant B.V., a developer of innovative fibrinogen technology, today announced that it has […]
Fibriant sponsors the 2016 International Fibrinogen Workshop in South Africa
Fibriant is one of the major sponsors of the XXIVth International Fibrinogen Workshop that will take place in the Kruger National Park, South Africa from 21 […]
Fibriant and AMOLF enter into Research Collaboration
Fibriant has entered into a collaborative research agreement with the AMOLF institute located in the Science Park Amsterdam. AMOLF is one of the research laboratories of the Foundation for […]